Conformal Medical Announces Launch of CONFORM Pivotal Trial

Study to support U.S. FDA approval of the novel CLAAS® implant for left atrial appendage occlusion (LAAO) and stroke prevention NASHUA, N.H., June 17, 2022 -- (Healthcare Sales & Marketing Network) -- Conformal Medical, Inc., a medical device compa... Devices, Interventional, Cardiology Conformal Medical, CLAAS System, atrial fibrillation, LAAO
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news